RecruitingNot ApplicableNCT06907095

Cohort Evaluation of Body Fluids Early Detection of Cancer in High-risk Individuals

A Prospective Cohort to Evaluate the Ability of Different Body fLuid-derived Approaches to Detect EArly-stage Cancers Among High-risk Individuals

Sponsor

Gustave Roussy, Cancer Campus, Grand Paris

Enrollment

5,909 participants

Start Date

Mar 16, 2026

Study Type

INTERVENTIONAL

Conditions

Risk of Breast Cancer Risk of Gynaecological Cancer Risk of Colorectal Cancer Risk of Upper Gastrointestinal Cancers Risk of Hepatic Cancers Risk of Lung Cancer Risk of Skin Cancers Except Basal-cell Carcinomas Risk of Head and Neck Cancers Risk of Mesothelioma Risk of Kidney Cancer Risk of Prostate Cancer Risk of Urothelial Cancers Risk of Endocrine Cancers Risk of Hematologic Malignancies Risk of Several Cancer Types Risk of Second Malignancy in Individuals Treated for a Childhood Cancer Risk of Neoplasia

Summary

LEAH is a prospective, observational, single-centre, non-randomised, open-label study of people at increased risk of cancer or malignant disease. The main objective of LEAH is to evaluate and compare the sensitivity of different tests on body fluids to detect cancers that will occur within 3 years of inclusion in the study, in a cohort of individuals identified as being at increased risk of cancer.

Eligibility

Min Age: 18 Years

Plain Language Summary

Simplified for easier understanding

This clinical trial is studying biological samples for people with risk of breast cancer, risk of colorectal cancer, and other related conditions. The study is currently recruiting participants at 1 location.

This summary was AI-generated to explain the trial in plain language. It is not medical advice. Always discuss eligibility with your doctor before enrolling in a clinical trial.

Interested in this trial?

Get notified about updates and connect with the research team.

Interventions

DIAGNOSTIC_TESTbiological samples

biological samples (blood, urine, saliva)

Locations(1)

Gustave Roussy

Villejuif, France

View Full Details on ClinicalTrials.gov

For the most up-to-date information, visit the official listing.

Visit

NCT06907095